0IP1.LSE Bastide le Confort Medical S.A.
- Market cap
- EUR 182M
- P/E
- -
- P/B
- -
- ROE
- 44.3%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Jun 2026.
Is 0IP1.LSE undervalued?
Graham numberThe Graham number of Bastide le Confort Medical S.A. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Bastide le Confort Medical S.A. fundamental analysis
No fundamental analysis for Bastide le Confort Medical S.A. yet.
Bastide le Confort Medical S.A. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Bastide le Confort Medical S.A.
Bastide Le Confort Médical SA, together with its subsidiaries, engages in the sale and rental of medical equipment in France, the United Kingdom, Belgium, Spain, Canada, the Netherlands, and Italy. It operates in six segments: Respiratory Assistance, Home Care, Healthcare Facilities, Nutrition/Infusion/Diabetes, Stoma Therapy/Urology/Wound Care, and E-commerce. The company offers reclining chairs, lift chairs, and accessories and tables for armchairs; incontinence products, …
Full company profileBastide le Confort Medical S.A. financial statements
Bastide le Confort Medical S.A. annual financial statements
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 218M | 289M | 336M | 383M | 444M | 468M | 508M | 530M | 491M | 482M |
| Gross Profit | 143M | 185M | 221M | 252M | 280M | 307M | 334M | 46.8M | 48.1M | 50.9M |
| Operating Income | 11.9M | 19.3M | 27.4M | 33.7M | 37.5M | 38.9M | 42.8M | 44.2M | 44.2M | 44.2M |
| EBITDA | 36.4M | 49.4M | 63.6M | 66.7M | 80.2M | 79.5M | 82.4M | 107M | 101M | 105M |
| Net Income | 5.43M | 7.16M | 4.57M | 11.6M | 13.5M | 13.7M | 16.1M | -900K | 528K | 58.1M |
| EPS | 0.74 | 0.98 | 0.62 | 1.58 | 1.83 | 1.86 | 2.02 | -0.12 | 0.07 | 7.89 |
| Balance Sheet | ||||||||||
| Total Assets | 258M | 384M | 396M | 506M | 569M | 633M | 657M | 647M | 661M | 576M |
| Total Liabilities | 195M | 315M | 329M | 426M | 484M | 546M | 569M | 566M | 590M | 445M |
| Shareholders' Equity | 61.9M | 66.7M | 63.4M | 75.7M | 81.3M | 84.6M | 87.6M | 79.8M | 72.1M | 131M |
| Cash & Short-term Investments | 14.4M | 28.7M | 21.3M | 35.4M | 33.7M | 22.1M | 36.7M | 23.6M | 25.5M | 48.2M |
| Total Debt | 132M | 215M | 213M | 306M | 358M | 419M | 427M | 409M | 411M | 299M |
| Cash Flow | ||||||||||
| Operating Cash Flow | 26.5M | 50.4M | 61.0M | 39.6M | 66.1M | 46.8M | 90.3M | 66.0M | 71.9M | 81.8M |
| Capital Expenditure | 27.0M | 38.3M | 34.4M | 39.8M | 46.5M | 53.3M | 53.6M | 55.4M | 60.1M | 51.0M |
| Free Cash Flow | -559K | 12.1M | 26.6M | -179K | 19.6M | -6.51M | 36.6M | 10.6M | 11.8M | 30.8M |
| Ratios | ||||||||||
| ROE | 8.8% | 10.7% | 7.2% | 15.3% | 16.5% | 16.2% | 18.3% | -1.1% | 0.7% | 44.3% |
| ROA | 2.1% | 1.9% | 1.2% | 2.3% | 2.4% | 2.2% | 2.4% | -0.1% | 0.1% | 10.1% |
| Net Profit Margin | 2.5% | 2.5% | 1.4% | 3.0% | 3.0% | 2.9% | 3.2% | -0.2% | 0.1% | 12.0% |
| Debt to Equity | 2.13x | 3.23x | 3.36x | 4.05x | 4.40x | 4.96x | 4.88x | 5.12x | 5.70x | 2.28x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Bastide le Confort Medical S.A. dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- 1.0%
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | 554K | 0.08 | 1.0% |
| 2025 | EUR 569K | 0.07 | 107.8% |
| 2024 | EUR 1.63M | 0.22 | - |
| 2023 | EUR 613K | 0.08 | 3.8% |
| 2022 | EUR 2.24M | 0.30 | 16.4% |
| 2021 | EUR 2.14M | 0.29 | 15.9% |
| 2020 | EUR 69.0K | 0.01 | 0.6% |
| 2019 | EUR 1.91M | 0.26 | 41.8% |
| 2018 | EUR 1.99M | 0.27 | 27.8% |
| 2017 | EUR 1.91M | 0.26 | 35.1% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Bastide le Confort Medical S.A.
- Insiders 55.79%
- Institutions 13.13%
- Public & others 31.09%
- Shares outstanding 7.32M
- Free float 3.39M
Bastide le Confort Medical S.A. company profile
- Company name
- Bastide le Confort Medical S.A.
- Ticker
- 0IP1.LSE
- Exchange
- London Exchange
- Sector
- Healthcare
- Industry
- Commercial Services & Supplies
- Employees
- 3,641
- Fiscal year end
- June
- Address
- Euro 2000 Centre, Caissargues, France, 30132
- Phone
- 33 4 66 38 68 08
- Website
- bastideleconfortmedical.com
About Bastide le Confort Medical S.A.
Bastide Le Confort Médical SA, together with its subsidiaries, engages in the sale and rental of medical equipment in France, the United Kingdom, Belgium, Spain, Canada, the Netherlands, and Italy. It operates in six segments: Respiratory Assistance, Home Care, Healthcare Facilities, Nutrition/Infusion/Diabetes, Stoma Therapy/Urology/Wound Care, and E-commerce. The company offers reclining chairs, lift chairs, and accessories and tables for armchairs; incontinence products, including sample wait, slip absorbent, adult complete change, incontinence diapers, and onesies, anatomical, male urinary, and right-hand protections, incontinence panties and swimsuits, disposable bed pads, support briefs, slips filets, feminine hygiene products, hygiene incontinence, and washable and reusable briefs and panties for urinary incontinence; and mobility products, such as walkers and rollators, walking sticks, electric scooters, and manual and electric wheelchairs. It also provides medical equipment comprising heating products, bathroom medical equipment, medical measuring device, medical pillow and cushion, technical support, electrostimulation and circulatory stimulators, pressotherapy device, pedal exerciser for seniors, seniors' telephone, bedside tables, medicalized room, sleep apnea device, natural food supplement, thermal compresses, pedicure and foot care, comfort shoes, first aid products, and wellness and health. In addition, the company offers professional equipment, which includes consumable for healthcare professionals, hygiene and disinfection, care and dressings, diagnosis and self-checking, and other medical equipment; and rental and services for medical bed, wheelchair, air mattress, patient lift, and verticalizer. It exports its products. The company was incorporated in 1976 and is headquartered in Caissargues, France. Bastide Le Confort Médical SA operates as a subsidiary of Societe d'Investissement Bastide SAS.
Bastide le Confort Medical S.A. management
5- Mr. Vincent BastideChairman & CEO
- Mr. Arnaud FayolleDeputy Chief Executive Officer
- Pierre-Marie VarachaudDeputy Chief Executive Officer
- Mr. Jeremy LugagneDeputy Chief Executive Officer
- Mr. Benjamin FerreDeputy Chief Executive Officer